PROspecTive Study on the use of gEriatriC assessment Tools for validation of 1- year mortality in non-metastatic breast cancer patients 65 years and older

The proposed study focuses on assessing the older patients (>/= 65 years) by using three geriatric scales. The aim of the study is to detect various problems faced by the older patients undergoing treatment for breast cancer. These include health related, social, psychological and economic problems. The four scales which will be used are Multidimensional prognostic index and Onco-multidimensional prognostic index, both of which involves a detailed assessment, VES-13 and G8 which are shorter tools. This assessment will be carried out at the beginning of the cancer directed treatment so that we can understand how treatment decisions (and subsequent survival) are affected by various factors in elderly patients. The quality of life will also be assessed using WHO-BREF questionnaire, which will be given at the time of initial assessment, after the completion of treatment and also during follow up every 6 months till 2 years. The   survival outcome and quality of life will be studied in relation to the geriatric scales data. Moreover, the usefulness of the short tools (G8 and VES-13) will be studied with respect to the longer MPI & onco-MPI tool to understand feasibility for routine clinical use. The study will be conducted over a 4-year period, 2 years for accrual of 300 patients and 2 years for follow up.